Pfizer's PFE stock has risen 5% since it reported first-quarter results on April 29. While the company beat estimates for ...

U.S. pharmaceutical imports surged in March, exceeding $50 billion, as drugmakers stockpiled inventory in anticipation of ...

President Donald Trump on Monday signed an executive order to incentivize drug manufacturing in the U.S., streamlining the ...

Pfizer Chief Executive Albert Bourla is equally worried. While agreeing on the need for a more secure drug supply, he doubts ...

Pfizer has promoted Albert Bourla, seen as a likely successor to incumbent CEO Ian Read, to the newly-created role of chief operating officer. The move could help Read focus on long-term strategy ...

Drugmaker executives have projected confidence they can mitigate the impact of any levies Trump imposes on the industry. Yet ...

The $40 billion investment will be spread across various R&D and manufacturing areas over the next five years.